Then, to determine if Cebpa plays a role in resolving lung fibrosis, we reversed the order of treatments, deleting Cebpa (via tamoxifen administration) 3 weeks after administering a bleomycin injury to initiate lung fibrosis (Figure 2M). This evidence concerns the gene CEBPA and pulmonary fibrosis.